These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 32138716)
1. LncRNA MAGI2-AS3 is downregulated in non-small cell lung cancer and may be a sponge of miR-25. Sui Y; Chi W; Feng L; Jiang J BMC Pulm Med; 2020 Mar; 20(1):59. PubMed ID: 32138716 [TBL] [Abstract][Full Text] [Related]
2. LncRNA Li F; Hu Q; Pang Z; Xu X Cancer Biother Radiopharm; 2020 Feb; 35(1):72-76. PubMed ID: 31910343 [No Abstract] [Full Text] [Related]
3. LncRNA MAGI2-As3 Suppresses the Proliferation and Invasion of Cervical Cancer by Sponging MiR-15b. Chai Y; Wang L; Qu Y; Hu Z J Healthc Eng; 2022; 2022():9707206. PubMed ID: 35126958 [TBL] [Abstract][Full Text] [Related]
4. LncRNA MAGI2-AS3 suppresses the proliferation and invasion of non-small cell lung carcinoma through miRNA-23a-3p/PTEN axis. Hao XZ; Yang K Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7399-7407. PubMed ID: 31539127 [TBL] [Abstract][Full Text] [Related]
5. LncRNA MAGI2-AS3 inhibites tumor progression by up-regulating STAM via interacting with miR-142-3p in clear cell renal cell carcinoma. Yang R; Chen Z; Ao S; Liang L; Chen Z; Duan X; Zeng G; Deng T Cell Signal; 2024 Jan; 113():110954. PubMed ID: 38084836 [TBL] [Abstract][Full Text] [Related]
6. LncRNA MAGI2-AS3 Inhibits Prostate Cancer Progression by Targeting the miR-142-3p. Hu R; Wu P; Liu J Horm Metab Res; 2022 Nov; 54(11):754-759. PubMed ID: 35944561 [TBL] [Abstract][Full Text] [Related]
7. LncRNA MAGI2-AS3 inhibits hepatocellular carcinoma cell proliferation and migration by targeting the miR-374b-5p/SMG1 signaling pathway. Yin Z; Ma T; Yan J; Shi N; Zhang C; Lu X; Hou B; Jian Z J Cell Physiol; 2019 Aug; 234(10):18825-18836. PubMed ID: 30924168 [TBL] [Abstract][Full Text] [Related]
8. lncRNA MAGI2-AS3 suppresses castration-resistant prostate cancer proliferation and migration via the miR-106a-5p/RAB31 axis. Yang G; Li T; Liu J; Quan Z; Liu M; Guo Y; Wu Y; Ou L; Wu X; Zheng Y Genomics; 2023 Mar; 115(2):110599. PubMed ID: 36889366 [TBL] [Abstract][Full Text] [Related]
9. LncRNA MAGI2-AS3 inhibits bladder cancer progression by targeting the miR-31-5p/TNS1 axis. Tang C; Cai Y; Jiang H; Lv Z; Yang C; Xu H; Li Z; Li Y Aging (Albany NY); 2020 Nov; 12(24):25547-25563. PubMed ID: 33231563 [TBL] [Abstract][Full Text] [Related]
10. LncRNA MAGI2-AS3 is downregulated in the distant recurrence of hepatocellular carcinoma after surgical resection and affects migration and invasion via ROCK2. Fang G; Wang J; Sun X; Xu R; Zhao X; Shao L; Sun C; Wang Y Ann Hepatol; 2020; 19(5):535-540. PubMed ID: 32546442 [TBL] [Abstract][Full Text] [Related]
11. LncRNA HOXC-AS3 increases non-small cell lung cancer cell migration and invasion by sponging premature miR-96. Wan L; Cheng Z; Sun Q; Jiang K Expert Rev Respir Med; 2022 May; 16(5):587-593. PubMed ID: 35034519 [TBL] [Abstract][Full Text] [Related]
12. MAGI2-AS3 and miR-374b-5p as Putative Regulators of Multiple Sclerosis via Modulating the PTEN/AKT/IRF-3/IFN-β Axis: New Clinical Insights. Kortam MA; Elfar N; Shaker OG; El-Boghdady NA; Abd-Elmawla MA ACS Chem Neurosci; 2023 Mar; 14(6):1107-1118. PubMed ID: 36878000 [TBL] [Abstract][Full Text] [Related]
13. LncRNA MAGI2-AS3 Affects Cell Invasion and Migration of Cervical Squamous Cell Carcinoma (CSCC) via Sponging miRNA-233/EPB41L3 Axis. Hou A; Zhang Y; Fan Y; Zheng Y; Zhou X; Liu H Cancer Manag Res; 2020; 12():4209-4216. PubMed ID: 32581592 [TBL] [Abstract][Full Text] [Related]
14. Identification and Verification of a Novel MAGI2-AS3/miRNA-374-5p/FOXO1 Network Associated with HBV-Related HCC. Wang C; Su K; Lin H; Cen B; Zheng S; Xu X Cells; 2022 Nov; 11(21):. PubMed ID: 36359865 [TBL] [Abstract][Full Text] [Related]
15. LncRNA MAGI2-AS3-Encoded Polypeptide Restrains the Proliferation and Migration of Breast Cancer Cells. Zhang Z; Yi Y; Wang Z; Zhang H; Zhao Y; He R; Luo Y; Cui Z Mol Biotechnol; 2024 Jun; 66(6):1409-1423. PubMed ID: 37358745 [TBL] [Abstract][Full Text] [Related]
16. LncRNA MIR17HG inhibits non-small cell lung cancer by upregulating miR-142-3p to downregulate Bach-1. Wei S; Liu J; Li X; Liu X BMC Pulm Med; 2020 Mar; 20(1):78. PubMed ID: 32228546 [TBL] [Abstract][Full Text] [Related]
17. Long Noncoding RNA MAGI2-AS3 Represses Cell Progression in Clear Cell Renal Cell Carcinoma by Modulating the miR-629-5p/PRDM16 Axis. Yan C; Wang P; Zhao C; Yin G; Meng X; Li L; Cai S; Meng B Crit Rev Eukaryot Gene Expr; 2023; 33(7):43-56. PubMed ID: 37602452 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA MAGI2-AS3 regulates CCDC19 expression by sponging miR-15b-5p and suppresses bladder cancer progression. Wang F; Zu Y; Zhu S; Yang Y; Huang W; Xie H; Li G Biochem Biophys Res Commun; 2018 Dec; 507(1-4):231-235. PubMed ID: 30442369 [TBL] [Abstract][Full Text] [Related]
19. Deregulated lncRNA MAGI2-AS3 in Alzheimer's disease attenuates amyloid-β induced neurotoxicity and neuroinflammation by sponging miR-374b-5p. Zhang J; Wang R Exp Gerontol; 2021 Feb; 144():111180. PubMed ID: 33279663 [TBL] [Abstract][Full Text] [Related]
20. Role of lncRNA MAGI2-AS3 in lipopolysaccharide-induced nucleus pulposus cells injury by regulating miR-374b-5p/interleukin-10 axis. Yu J; Li C Immun Inflamm Dis; 2023 Apr; 11(4):e772. PubMed ID: 37102649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]